
ARKK Holdings of Iovance Biotherapeutics (IOVA) - Updated Daily
Earnings Date: Thursday, Feb 25th
Key Statistics
Description | |
---|---|
Iovance Biotherapeutics Inc is a biopharmaceutical company in the United States. Its lead pipeline candidate, LN-144, uses the tumor-infiltrating lymphocytes to treat serious diseases. | |
Website | |
http://lbio.com/ | |
📅 Next Earnings Date | |
February 25th 2021 |
Research Notes and Commentary for IOVA
July 6, 2020